JPH0742231B2 - Ｍ１−選択的な抗ムスカリン性ピリドベンゾジアゼピノン類を含む眼科用薬剤 - Google Patents

Ｍ１−選択的な抗ムスカリン性ピリドベンゾジアゼピノン類を含む眼科用薬剤

Info

Publication number
JPH0742231B2
JPH0742231B2 JP5005813A JP581393A JPH0742231B2 JP H0742231 B2 JPH0742231 B2 JP H0742231B2 JP 5005813 A JP5005813 A JP 5005813A JP 581393 A JP581393 A JP 581393A JP H0742231 B2 JPH0742231 B2 JP H0742231B2
Authority
JP
Japan
Prior art keywords
myopia
eye
formula
drug
pirenzepine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP5005813A
Other languages
English (en)
Japanese (ja)
Other versions
JPH06206820A (ja
Inventor
ピエール・マロルガ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JPH06206820A publication Critical patent/JPH06206820A/ja
Publication of JPH0742231B2 publication Critical patent/JPH0742231B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP5005813A 1992-01-21 1993-01-18 Ｍ１−選択的な抗ムスカリン性ピリドベンゾジアゼピノン類を含む眼科用薬剤 Expired - Lifetime JPH0742231B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82349592A 1992-01-21 1992-01-21
US823495 1992-01-21

Publications (2)

Publication Number Publication Date
JPH06206820A JPH06206820A (ja) 1994-07-26
JPH0742231B2 true JPH0742231B2 (ja) 1995-05-10

Family

ID=25238929

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5005813A Expired - Lifetime JPH0742231B2 (ja) 1992-01-21 1993-01-18 Ｍ１−選択的な抗ムスカリン性ピリドベンゾジアゼピノン類を含む眼科用薬剤

Country Status (10)

Country Link
EP (1) EP0556947A1 (enExample)
JP (1) JPH0742231B2 (enExample)
CN (1) CN1074606A (enExample)
AU (1) AU3192393A (enExample)
CA (1) CA2087510A1 (enExample)
IL (1) IL104409A0 (enExample)
MX (1) MX9300250A (enExample)
TW (1) TW222583B (enExample)
WO (1) WO1993013777A1 (enExample)
ZA (2) ZA93374B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122522A (en) * 1989-06-21 1992-06-16 The Trustees Of The University Of Pennsylvania Treatment and control of ocular development
AU5312198A (en) * 1997-01-06 1998-08-03 Klaus Trier Aps Screening method
US9827250B2 (en) 2012-07-31 2017-11-28 Johnson & Johnson Vision Care, Inc. Lens incorporating myopia control optics and muscarinic agents
JP6784407B2 (ja) * 2015-04-24 2020-11-11 学校法人慶應義塾 近視予防剤及び近視進行抑制剤
GB201510010D0 (en) 2015-06-09 2015-07-22 King S College London PDD and BPD compounds
GB201514928D0 (en) 2015-08-21 2015-10-07 King S College London PDD compounds
US20180339985A1 (en) 2015-08-21 2018-11-29 Femtogenix Limited Pdd compounds
US12298602B2 (en) 2015-09-15 2025-05-13 Largan Medical Co., Ltd. Multifocal contact lens and contact lens product
CN110308570A (zh) 2015-09-15 2019-10-08 星欧光学股份有限公司 隐形眼镜产品
US10845622B2 (en) 2015-09-15 2020-11-24 Largan Medical Co., Ltd. Multifocal contact lens and contact lens product
CN115414357B (zh) * 2022-08-30 2023-09-22 天津医科大学眼科医院 一种酰胺类化合物在制备防治近视的药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1212742B (it) * 1983-05-17 1989-11-30 Dompe Farmaceutici Spa Derivati dibenzo [1,4]diazepinonici pirido [1,4] benzodiazepinonici,pirido [1,5] benzodiazepinonici e loro attivita' farmacologica
ATE183085T1 (de) * 1989-06-21 1999-08-15 Univ Pennsylvania Behandlung und regulierung der augenentwicklung mit cholinergischen agonisten

Also Published As

Publication number Publication date
WO1993013777A1 (en) 1993-07-22
EP0556947A1 (en) 1993-08-25
MX9300250A (es) 1993-07-01
AU3192393A (en) 1993-07-22
CN1074606A (zh) 1993-07-28
IL104409A0 (en) 1993-05-13
JPH06206820A (ja) 1994-07-26
ZA93374B (en) 1993-08-23
ZA93384B (en) 1993-08-23
TW222583B (enExample) 1994-04-21
CA2087510A1 (en) 1993-07-22

Similar Documents

Publication Publication Date Title
US5122522A (en) Treatment and control of ocular development
JPH0742231B2 (ja) Ｍ１−選択的な抗ムスカリン性ピリドベンゾジアゼピノン類を含む眼科用薬剤
EP4324463A1 (en) Method and pharmaceutical composition for treating myopia
JP3461778B2 (ja) 眼の発達の治療及び制御
US5952338A (en) Agent for prophylaxis and treatment of disturbance of visual function
AU677860B2 (en) Composition for prophylaxis and treatment of myopia
US5360801A (en) Pharmacological stimulation of eye growth
JP3066561B2 (ja) 近視予防・治療剤
JPH10203982A (ja) 視機能障害の予防・治療剤
CA2187361A1 (en) Pharmaceutical composition for treating glaucoma containing terazosin
JPS6256130B2 (enExample)
HK40069144A (en) Methods and pharmaceutical compositions for treating myopia
CN119424422A (zh) 眼科药物组合物、用途及其制剂
KR20000013487A (ko) 글리코피롤레이트를 유효성분으로 하는 근시예방 및 치료용 조성물
KR19990080875A (ko) 갈라민을 유효성분으로 하는 근시예방 및 치료용 조성물
MXPA97005077A (en) Agent for prophylaxis and treatment of vision function disorder
HK1007681B (en) Use of pirenzepine, telenzepine oder o-methoxy-sila-hexocyclium in the manufacture of a medicament for the treatment and control of ocular development
JPWO1998029135A1 (ja) 眼循環障害改善剤